Vimarsana
Biggest News Aggregation in the World

Page 7 - Milestone Payment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Milestone Payment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Milestone Payment Today - Breaking & Trending Today

Nascent Biotech Inc.: Nascent Biotech Receives $750k Milestone Payment from BioRay Pharmaceutical - Vimarsana News

Nascent Biotech Inc.: Nascent Biotech Receives $750k Milestone Payment from BioRay Pharmaceutical

Milestone Payment is the Second of Four in $5M Pritumumab Licensing DealVERO BEACH, FL / ACCESSWIRE / February 23, 2022 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company")

Aardvark Capital Corp.: Aardvark Capital and 2766604 Ontario Ltd. Execute Business Combination Agreement for Proposed Qualifying Transaction and Announce Upsizing of Previously Announced Private Placement of Subscription Receipts - Vimarsana News

Aardvark Capital Corp.: Aardvark Capital and 2766604 Ontario Ltd. Execute Business Combination Agreement for Proposed Qualifying Transaction and Announce Upsizing of Previously Announced Private Placement of Subscription Receipts

Toronto, Ontario--(Newsfile Corp. - December 24, 2021) - Aardvark Capital Corp. (TSXV: ACCA.P) (the "Company") and 2766604 Ontario Ltd. ("GoldCo", and together with the Company, the "Parties") are pleased

Basilea Pharmaceutica AG: Basileas Partner Asahi Kasei Pharma reicht Antrag auf Marktzulassung (NDA) von Isavuconazol in Japan ein - Vimarsana News

Basilea Pharmaceutica AG: Basileas Partner Asahi Kasei Pharma reicht Antrag auf Marktzulassung (NDA) von Isavuconazol in Japan ein

Ad hoc-Mitteilung gemäss Art. 53 KR Basel, 30. September 2021 Basilea Pharmaceutica AG (SIX: BSLN) gab heute bekannt, dass ihr Partner Asahi Kasei Pharma Corporation (Asahi Kasei Pharma) in Japan

SMI fester gesehen - Vimarsana News

SMI fester gesehen

Die Schweizer Börse kann ihren Erholungskurs nicht fortsetzen. Der Leitindex verliert mehr als 6% im September. Im Fokus steht Börsenneuling Medmix. Der Euro rutscht unter 1.16 $.

Source: fuw.ch
Thomas Christély verstärkt Management der MetrioPharm AG als CEO - Vimarsana News

Thomas Christély verstärkt Management der MetrioPharm AG als CEO

Zum 1. Oktober 2021 beginnt Thomas Christély als CEO der MetrioPharm AGDr. Wolfgang Brysch forciert als CSO & CMO den Ausbau der klinischen Entwicklung ZÜRICH, Schweiz, Aug. 19, 2021 (GLOBE NEWSWIRE)